Fangzhou Inc. Stock

Equities

6086

KYG3314S1066

Drug Retailers

Market Closed - Hong Kong S.E. 04:08:09 2024-07-16 EDT 5-day change 1st Jan Change
4.6 HKD -4.76% Intraday chart for Fangzhou Inc. 0.00% 0.00%

Financials

Sales 2022 2.2B 303M 2.37B 415M Sales 2023 2.43B 335M 2.61B 458M Capitalization 6.03B 829M 6.47B 1.13B
Net income 2022 -383M -52.7M -411M -72.05M Net income 2023 -197M -27.11M -212M -37.06M EV / Sales 2022 * -
Net cash position 2022 * - 0 0 0 Net cash position 2023 * - 0 0 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 515
Yield 2022 *
-
Yield 2023 *
-
Free-Float 3.75%
More Fundamentals * Assessed data
Dynamic Chart
1 week
4.50
Extreme 4.5
6.71
1 month
4.30
Extreme 4.3
6.71
Current year
4.30
Extreme 4.3
6.71
1 year
4.30
Extreme 4.3
6.71
3 years
4.30
Extreme 4.3
6.71
5 years
4.30
Extreme 4.3
6.71
10 years
4.30
Extreme 4.3
6.71
More quotes
Date Price Change Volume
24-07-16 4.6 -4.76% 737,000
24-07-15 4.83 -10.56% 468,000
24-07-12 5.4 -14.29% 1,013,000
24-07-11 6.3 +7.88% 3,075,000
24-07-10 5.84 +28.92% 3,137,500

Delayed Quote Hong Kong S.E., July 16, 2024 at 04:08 am

More quotes
Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The Company operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.
More about the company